Morning Market Losers

Akorn (NASDAQ: AKRX ) plummeted 11.98% to $22.73 after the company reported Q4 results and issued a weak FY14 guidance. Celldex Therapeutics (NASDAQ: CLDX ) dropped 11.81% to $25.77 on Q4 results. Celldex posted a Q4 loss of $0.27 per share. Central European Media Enterprises (NASDAQ: CETV ) shares